The WHO Vaccine Trial Registry.
The WHO Vaccine Trial Registry prospectively registers clinical vaccine studies supported by WHO. Through December 1999, the registry includes 103 studies from 43 countries, with nearly 80% in developing countries. The registry documents an expanding research capacity, with an average of 3.9 new studies per year during 1987-1993, rising to 10.7 per year during 1994-2000. The studies concern a broad spectrum of infectious organisms, including: Clostridium tetani (tetanus), dengue virus, enterotoxigenic Escherichia coli (ETEC), Haemophilus influenzae type b (Hib), hepatitis B virus, measles virus, Mycobacterium tuberculosis, Neisseria meningitidis (meningococcus), poliovirus, respiratory syncytial virus (RSV), rotavirus, Salmonella typhi, Shigella, Streptococcus pneumoniae (pneumococcus), and Vibrio cholerae.
Robertson
S E
SE
Department of Vaccines and Biologicals, World Health Organization, CH-1211 27, Geneva, Switzerland. robertsons@who.int
Mayans
M V
MV
El-Husseiny
A
A
Clemens
J D
JD
Ivanoff
B
B
D016907:Adverse Drug Reaction Reporting Systems / Q000458:organization & administration; D001428:Bacterial Vaccines; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data*; D003906:Developing Countries; D014943:Global Health; D006801:Humans; D020407:Internet; D015337:Multicenter Studies as Topic; D012042:Registries; D012107:Research Design; D012109:Research Support as Topic; D014611:Vaccination / Q000009:adverse effects / Q000706:statistics & numerical data*; D014612:Vaccines / Q000009:adverse effects; D014765:Viral Vaccines; D014944:World Health Organization / Q000458:organization & administration*
D001428:Bacterial Vaccines; D014612:Vaccines; D014765:Viral Vaccines